Operating Margin of Altimmune, Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Altimmune, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Altimmune, Inc. Operating Margin for the quarter ending 30 Sep 2025 was -452310%, a 110% decline year-over-year.
  • Altimmune, Inc. annual Operating Margin for 2024 was -515860%, a 2191% decline from 2023.
  • Altimmune, Inc. annual Operating Margin for 2023 was -22519%, a 117% decline from 2022.
  • Altimmune, Inc. annual Operating Margin for 2022 was 129029%.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Altimmune, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -452310% -237062% -110% 01 Jul 2025 30 Sep 2025
Q2 2025 -471850% -445028% -1659% 01 Apr 2025 30 Jun 2025
Q1 2025 -490965% -466340% -1894% 01 Jan 2025 31 Mar 2025
Q4 2024 -515860% -493341% -2191% 01 Oct 2024 31 Dec 2024
Q3 2024 -215248% -184639% -603% 01 Jul 2024 30 Sep 2024
Q2 2024 -26822% -134985% -125% 01 Apr 2024 30 Jun 2024
Q1 2024 -24625% -138549% -122% 01 Jan 2024 31 Mar 2024
Q4 2023 -22519% -151548% -117% 01 Oct 2023 31 Dec 2023
Q3 2023 -30609% 01 Jul 2023 30 Sep 2023
Q2 2023 108163% 01 Apr 2023 30 Jun 2023
Q1 2023 113924% 01 Jan 2023 31 Mar 2023
Q4 2022 129029% 01 Oct 2022 31 Dec 2022

Altimmune, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -515860% -493341% -2191% 01 Jan 2024 31 Dec 2024
2023 -22519% -151548% -117% 01 Jan 2023 31 Dec 2023
2022 129029% +131227% 01 Jan 2022 31 Dec 2022
2021 -2198% 01 Jan 2021 31 Dec 2021
2011 -48% +64% +57% 01 Jan 2011 31 Dec 2011
2010 -112% 01 Jan 2010 31 Dec 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.